Compare VERA & AEHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VERA | AEHR |
|---|---|---|
| Founded | 2016 | 1977 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.0B |
| IPO Year | 2021 | 1997 |
| Metric | VERA | AEHR |
|---|---|---|
| Price | $32.17 | $123.68 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 3 |
| Target Price | ★ $81.30 | $29.50 |
| AVG Volume (30 Days) | 1.9M | ★ 2.6M |
| Earning Date | 05-06-2026 | 04-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $50,001,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $472.48 | $71.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $21.15 | $16.38 |
| 52 Week High | $56.05 | $147.40 |
| Indicator | VERA | AEHR |
|---|---|---|
| Relative Strength Index (RSI) | 44.41 | 58.57 |
| Support Level | $30.07 | $75.30 |
| Resistance Level | $32.44 | $126.62 |
| Average True Range (ATR) | 1.66 | 13.76 |
| MACD | 0.15 | 4.41 |
| Stochastic Oscillator | 71.44 | 69.02 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.